Abstract
Polycystic ovary syndrome (PCOS) has been associated with higher miscarriage rates in patients undergoing in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). Elevated anti-mullerian hormone (AMH) in PCOS patients has been associated with a more severe phenotype. This study seeks to determine whether subjects with a high AMH undergoing IVF/ICSI with preimplantation genetic testing for aneuploidy (PGT-A) have aneuploidy rates that differ from cohorts with low or normal AMH levels and whether this relationship is modified by PCOS.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
